SMLR vs. SLNO, INMD, CDRE, MDXG, BLFS, RXST, AORT, EMBC, PLSE, and LQDA
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Soleno Therapeutics (SLNO), InMode (INMD), Cadre (CDRE), MiMedx Group (MDXG), BioLife Solutions (BLFS), RxSight (RXST), Artivion (AORT), Embecta (EMBC), Pulse Biosciences (PLSE), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.
Semler Scientific vs.
Soleno Therapeutics (NASDAQ:SLNO) and Semler Scientific (NASDAQ:SMLR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.
Soleno Therapeutics has a beta of -1.47, meaning that its share price is 247% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.
97.4% of Soleno Therapeutics shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 12.3% of Soleno Therapeutics shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Soleno Therapeutics received 309 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 72.09% of users gave Soleno Therapeutics an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote.
Semler Scientific has a net margin of 27.00% compared to Soleno Therapeutics' net margin of 0.00%. Semler Scientific's return on equity of 20.31% beat Soleno Therapeutics' return on equity.
In the previous week, Semler Scientific had 1 more articles in the media than Soleno Therapeutics. MarketBeat recorded 3 mentions for Semler Scientific and 2 mentions for Soleno Therapeutics. Soleno Therapeutics' average media sentiment score of 1.04 beat Semler Scientific's score of 0.54 indicating that Soleno Therapeutics is being referred to more favorably in the media.
Soleno Therapeutics presently has a consensus price target of $74.83, indicating a potential upside of 59.63%. Given Soleno Therapeutics' higher probable upside, research analysts plainly believe Soleno Therapeutics is more favorable than Semler Scientific.
Semler Scientific has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Summary
Semler Scientific beats Soleno Therapeutics on 11 of the 17 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
This page (NASDAQ:SMLR) was last updated on 1/21/2025 by MarketBeat.com Staff
Free SMLR Stock Alerts